Indeed, in an older cohort, the prevalence of relevant cancer was significantly increased among individuals with a heterozygous P/LP variant: 4.11-fold for females with a heterozygous P/LP BRCA1/2 variant and 12.77-fold for individuals with a P/LP Lynch syndrome variant(12). This evidence concerns the gene BRCA1 and cancer.